Skip to main
CLPT

CLPT Stock Forecast & Price Target

CLPT Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ClearPoint Neuro Inc has demonstrated a compelling growth trajectory, closing 2023 with a 17% increase in topline revenue and a notable reduction in cash burn, highlighting its improved financial health. The company is positioned for continued success in 2024, with expectations of at least 20% revenue growth driven by an expanding partnership base and enhanced service offerings. Additionally, recent key product approvals and increased system installations contribute to a strong foundation for sustainable growth and profitability moving forward.

Bears say

ClearPoint Neuro Inc. has demonstrated a significant reduction in cash burn, decreasing from $5.8 million in the first quarter of 2023 to $1.2 million in the fourth quarter, which may indicate improved operational efficiency. Despite this positive trend in cash management, the company's financial health remains a concern, as sustained high cash burn levels in earlier quarters could imply challenges in revenue generation and profitability. Ultimately, ClearPoint Neuro's ability to control cash outflows will be critical, but the underlying financial metrics suggest potential risks in achieving long-term growth and stability.

CLPT has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Clearpoint Neuro Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Clearpoint Neuro Inc (CLPT) Forecast

Analysts have given CLPT a Strong Buy based on their latest research and market trends.

According to 2 analysts, CLPT has a Strong Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Clearpoint Neuro Inc (CLPT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.